Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
PDLI similar filings
- 8 Mar 12 PDL BioPharma Provides First Quarter 2012 Royalty Revenue Guidance of $77 Million
- 6 Mar 12 Regulation FD Disclosure
- 5 Mar 12 Other Events
- 28 Feb 12 Regulation FD Disclosure
- 23 Feb 12 PDL BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results
- 17 Feb 12 Departure of Directors or Certain Officers
- 13 Feb 12 Regulation FD Disclosure
Filing view
External links
Exhibit 99.1
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide1.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide2.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide3.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide4.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide5.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide6.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide7.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide8.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide9.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide10.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide11.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide12.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide13.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide14.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide15.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide16.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide17.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide18.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide19.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide20.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide21.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide22.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide23.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide24.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide25.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide26.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide27.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide28.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide29.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide30.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide31.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide32.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide33.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide34.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-001812/slide35.jpg)